Organigram Global (OGI) Retained Earnings (2018 - 2026)

Organigram Global (OGI) posted quarterly Retained Earnings of -$430.0 million for Q1 2026, down 1.85% on a QoQ basis from -$422.2 million in Q4 2025.

Organigram Global (OGI) Retained Earnings (2018 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Retained Earnings for 9 consecutive years, with -$430.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Retained Earnings changed N/A year-over-year to -$430.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$430.0 million (changed N/A YoY) and the FY2025 annual result came in at -$422.2 million, changed N/A from the prior year.
  • Retained Earnings fell to -$430.0 million in Q1 2026 per OGI's latest filing, from -$422.2 million in the prior quarter.
  • Over the last five years, Retained Earnings for OGI reached as high as -$46182.4 in Q3 2024 and fell as low as -$442.3 million in Q3 2025.
  • A 5-year average of -$320.2 million and a median of -$411.9 million in 2023 frame the typical range for Retained Earnings.
  • Annual changes were most pronounced in 2024 — Retained Earnings jumped 99.99% — and 2025, when it slumped 957673.27%.
  • Year by year, Retained Earnings stood at -$225.1 million in 2022, then slumped by 78.43% to -$401.7 million in 2023, then soared by 99.99% to -$46182.4 in 2024, then sank by 914080.74% to -$422.2 million in 2025, then dropped by 1.85% to -$430.0 million in 2026.
  • According to Business Quant data, Retained Earnings over the past three periods registered -$430.0 million, -$422.2 million, and -$442.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 37.04 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 28.20 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.11 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.54 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 8.83 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -1.81 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 18.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 589.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.13 Bn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn -430.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -430.00 Mn
Dec 31, 2025 -422.19 Mn
Sep 30, 2025 -442.32 Mn
Sep 30, 2024 -46,182.36
Sep 30, 2023 -401.70 Mn
Aug 31, 2022 -225.13 Mn
Nov 30, 2021 -276.95 Mn
Aug 31, 2021 -275.64 Mn
May 31, 2021 -249.67 Mn
Feb 28, 2021 -245.67 Mn
Nov 30, 2020 -179.28 Mn
Aug 31, 2020 37,208.64
May 31, 2020 -76.05 Mn
Feb 29, 2020 -16.48 Mn
Aug 31, 2019 -32,524.97
May 31, 2019 34,000.00
Aug 31, 2018 579,693.72